Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any cone-rod dystrophy in which the cause of the disease is a mutation in the RPGRIP1 gene.
Features include always present findings: Constriction of peripheral visual field, Abnormality of fundus pigmentation, Hypermetropia, and Photophobia and others; and very common findings: Nyctalopia. 25 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 9 | Nystagmus, Macular atrophy, Posterior subcapsular cataract |
RPGRIP1 function has not been fully characterized.
Cone-rod dystrophy 13 is associated with mutations in the RPGRIP1 gene on chromosome 14.
Genetic testing for RPGRIP1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for cone-rod dystrophy 13 has been reported in the published literature.
Phenotype severity distribution: 10 always present features, 1 very common feature, 7 common features.
No clinical trials have been registered for cone-rod dystrophy 13.
12 publications have been identified in PubMed for cone-rod dystrophy 13. Research spans Case Report / Case Series (27%), Basic Science / Preclinical (27%), and Epidemiology / Natural History (27%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 3 | 27% |
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 8:09 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Common questions about cone-rod dystrophy 13
Bones and joints
1 |
Bone spicule pigmentation of the retina |
Muscles | 1 | Macular atrophy |
3 |
27% |
Disease patterns and progression | 3 | 27% |
Testing and diagnosis research | 1 | 9% |
Research summaries | 1 | 9% |
Mizobuchi K (2026). [PMID: 42102949](https://pubmed.ncbi.nlm.nih.gov/42102949/). *Am J Ophthalmol*. [Epidemiology / Natural History]
Kwok JC (2026). [PMID: 39428496](https://pubmed.ncbi.nlm.nih.gov/39428496/). *Vet Ophthalmol*. [Case Report / Case Series]
Park HS (2025). [PMID: 40296824](https://pubmed.ncbi.nlm.nih.gov/40296824/). *J Korean Med Sci*. [Review / Meta-Analysis]
Salameh M (2025). [PMID: 40674075](https://pubmed.ncbi.nlm.nih.gov/40674075/). *JAMA Ophthalmol*. [Basic Science / Preclinical]
Vanita V (2025). [PMID: 41003791](https://pubmed.ncbi.nlm.nih.gov/41003791/). *Mol Biol Rep*. [Basic Science / Preclinical]
Karuntu JS (2025). [PMID: 39665295](https://pubmed.ncbi.nlm.nih.gov/39665295/). *Acta Ophthalmol*. [Diagnostic / Biomarker]
Holland J (2025). [PMID: 41091173](https://pubmed.ncbi.nlm.nih.gov/41091173/). *Graefes Arch Clin Exp Ophthalmol*. [Epidemiology / Natural History]
Uner OE (2025). [PMID: 39763288](https://pubmed.ncbi.nlm.nih.gov/39763288/). *Ophthalmic Genet*. [Epidemiology / Natural History]
Li M (2025). [PMID: 41381383](https://pubmed.ncbi.nlm.nih.gov/41381383/). *Mol Genet Genomic Med*. [Case Report / Case Series]
Daich Varela M (2024). [PMID: 38768745](https://pubmed.ncbi.nlm.nih.gov/38768745/). *Am J Ophthalmol*. [Case Report / Case Series]
AI-curated news mentioning cone-rod dystrophy 13
Updated Jun 1, 2026
Researchers identified a novel mutation in the CEP78 gene associated with cone-rod dystrophy and hearing loss. This discovery enhances understanding of the genetic basis for these conditions and may inform future therapeutic strategies.